Evidence map›Paper›PMID 33405048›Full record

ArticleJournal of bioenergetics and biomembranes2021

Collagen type VIII alpha 2 chain (COL8A2), an important component of the basement membrane of the corneal endothelium, facilitates the malignant development of glioblastoma cells via inducing EMT.

Ying-Xin Cheng, Lin Xiao, Yan-Li Yang, Xiao-Dong Liu, Xiu-Rong Zhou, Zhen-Fu Bu, Pei-Cheng Cao, Dao-Kui Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bioenergetics and biomembranes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The functional role of the extracellular matrix in inflammatory bowel disease associated gut fibrosis.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  6. Article
  7. Collagen VIII in vascular diseases.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ying-Xin ChengDepartment of Neurosurgery, Wei Fang People's Hospital, No. 151 Guangwen Street, Weifang, Shandong, 261041, People's Republic of China.
Lin XiaoDepartment of Biochemistry, Weifang Medical University, Weifang, Shandong, 261053, People's Republic of China.
Yan-Li YangDepartment of Neurosurgery, Wei Fang People's Hospital, No. 151 Guangwen Street, Weifang, Shandong, 261041, People's Republic of China. cqykdx@189.cn.
Xiao-Dong LiuDepartment of Neurosurgery, Wei Fang People's Hospital, No. 151 Guangwen Street, Weifang, Shandong, 261041, People's Republic of China.
Xiu-Rong ZhouDepartment of Neurosurgery, Wei Fang People's Hospital, No. 151 Guangwen Street, Weifang, Shandong, 261041, People's Republic of China.
Zhen-Fu BuDepartment of Neurosurgery, Wei Fang People's Hospital, No. 151 Guangwen Street, Weifang, Shandong, 261041, People's Republic of China.
Pei-Cheng CaoDepartment of Neurosurgery, Wei Fang People's Hospital, No. 151 Guangwen Street, Weifang, Shandong, 261041, People's Republic of China.
Dao-Kui WangDepartment of Neurosurgery, Wei Fang People's Hospital, No. 151 Guangwen Street, Weifang, Shandong, 261041, People's Republic of China.
Weifang People's Hospital · CNWeifang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GBM) is one of the most lethal tumor of all human cancers. Due to its poor response to chemotherapy and radiotherapy as well as its high rate of recurrence after treatment, the treatment is still undesired. The identification of potential related genes and bio-markers in the development of GBM could provide some new targets for the treatment of GBM. Our purpose in this study was to evaluate the mission of COL8A2 in GBM. Combined with TCGA, Oncomine databases, CGGA, GEPIA website and qRT-PCR analyses, we found that COL8A2 was up-regulated both in GBM tissues and cells compared to the controls. Moreover, the high COL8A2 expression was associated with the shorter overall survival of patients with GBM. The expression of COL8A2 was also positively correlated with metastasis-associated genes including vimentin, snail, slug, MMP2 and MMP7 according to GEPIA website. Knockdown of COL8A2 could suppress the cell proliferation, cell migration and invasion, whereas the overexpression of COL8A2 significantly expedited these processes. What's more, the outcome of western blot analysis manifested that COL8A2 could induced the expression of vimentin, snail, slug, MMP2 and MMP7. Taken together, COL8A2 activated cell proliferation, cell migration and invasion via raising the relative expression of EMT-related proteins in GBM. Therefore, our investigation suggests the oncogenic role of COL8A2 in GBM and provides a potential application of COL8A2 for GBM therapy.

Indexed as

Basement MembraneBrain NeoplasmsCollagen Type VIIIEndothelium, CornealEpithelial-Mesenchymal TransitionGlioblastomaHumansTransfectionCOL8A2 protein, humanCollagen Type VIIICorrelationEpithelial–mesenchymal transitionGlioblastomaInvasionProgression

Identifiers

PMID33405048
OpenAlexW3118957151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.